UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000012545
Receipt No. R000014681
Official scientific title of the study A study of safety and efficacy of robot assisted surgery
Date of disclosure of the study information 2013/12/11
Last modified on 2018/12/17 (Ver. 11)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study A study of safety and efficacy of robot assisted surgery
Title of the study (Brief title) Aimed to find out how inflammation will be develop during robot assisted surgery
Region
Japan

Condition
Condition malignant tumor of the bladder
Classification by specialty
Urology Anesthesiology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 Aimed to find out how inflammation will be develop during robot assisted surgery
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes To estimate safety and efficacy of robot assisted surgery with quantifing stress and inflammation related substance.
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patient who has robot assisted surgery for bladder malignant tumor
Key exclusion criteria Patient wothout inforned consent, who has robot assisted surgery for bladder malignant tumor
Target sample size 15

Research contact person
Name of lead principal investigator Tetsuya Kushikata
Organization Hirosaki University
Division name Department of Anesthesiology, Graduate School of Medicine
Address Zaifu 5, Hirosaki, Aomori
TEL 0172335111
Email tetsuyak@cc.hirosaki-u.ac.jp

Public contact
Name of contact person Tetsuya Kushikata
Organization Hirosaki University
Division name Department of Anesthesiology, Graduate School of Medicine
Address Zaifu 5, Hirosaki, Aomori
TEL 0172335111
Homepage URL
Email tetsuyak@cc.hirosaki-u.ac.jp

Sponsor
Institute Department of Anesthesiology, Hirosaki University Graduate School of Medicine
Institute
Department

Funding Source
Organization N/A
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2013 Year 12 Month 11 Day

Progress
Recruitment status Completed
Date of protocol fixation
2013 Year 11 Month 28 Day
Anticipated trial start date
2013 Year 12 Month 11 Day
Last follow-up date
2018 Year 12 Month 11 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results analysis data obtained
Other related information Robot-assisted surgery has a merit of low-invasive. It is expected to reduce blood-loss and wound size even though in case of high invasive surgery like total cystectomy.
Robot-assisted surgery has different approach from ordinary laparotomy; thus, it may possible to develop unexpected complication mesenteric traction syndrome. Purpose of this study is to evaluate safety and efficacy of a robot-assisted surgery. We investigate usual blood examination and changes in stress/inflammation related substances (catecholamine, cortisol, orexin, urotensin II, procalcitonin, presepsin, endotoxin, etc.).

Management information
Registered date
2013 Year 12 Month 11 Day
Last modified on
2018 Year 12 Month 17 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000014681